Sangal Papers (BOM:516096) Other Stockholders Equity: ₹454 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:516096 Sangal Papers Ltd BOM:516096
58 GF Score
Price ₹175.00
GF Value ₹180.74
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sangal Papers Other Stockholders Equity?

Sangal Papers BOM:516096 58 Other Stockholders Equity is ₹454 Mil as of Mar. 2026. GuruFocus rates BOM:516096 with a GF Score™ of 58/100 and a GF Value™ of ₹180.74 (Fairly Valued). The stock has 4 warning signs investors should review.

Sangal Papers's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ₹454 Mil.

Sangal Papers's quarterly Other Stockholders Equity declined from Sep. 2025 (₹441 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹454 Mil).

Sangal Papers's annual Other Stockholders Equity stayed the same from Mar. 2024 (₹5 Mil) to Mar. 2025 (₹5 Mil) but then increased from Mar. 2025 (₹5 Mil) to Mar. 2026 (₹454 Mil).

Sangal Papers Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Sangal Papers's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sangal Papers Other Stockholders Equity Chart

Sangal Papers Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.86 4.86 4.86 4.86 454.25

Sangal Papers Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.86 0.00 441.34 0.00 454.25
BOM:516096
58GF Score
Sangal Papers Ltd BOM:516096
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sangal Papers Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹454 Mil mean?
Sangal Papers (BOM:516096) has a Other Stockholders Equity of ₹454 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sangal Papers and its competitors.
Is Sangal Papers' Other Stockholders Equity too high?
Sangal Papers' current Other Stockholders Equity is ₹454 Mil. Overall, Sangal Papers has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sangal Papers' Other Stockholders Equity compare to competitors?
Sangal Papers' Other Stockholders Equity of ₹454 Mil can be compared against companies in the Forest Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Forest Products company?
A good Other Stockholders Equity depends on the Forest Products industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sangal Papers and its competitors. Sangal Papers's current Other Stockholders Equity is ₹454 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sangal Papers stock overvalued right now?
Based on GuruFocus' analysis, Sangal Papers (BOM:516096) is currently considered Fairly Valued. The stock's GF Value™ is ₹180.74, compared to a current price of ₹175.00 — trading 3.2% below its estimated fair value. The current Other Stockholders Equity is ₹454 Mil. Sangal Papers' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Sangal Papers (BOM:516096), the current Other Stockholders Equity is ₹454 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sangal Papers (BOM:516096) Overvalued in 2026?

Based on GuruFocus' analysis, Sangal Papers stock appears to be undervalued. The current stock price of ₹175.00 is trading 3.2% below its estimated GF Value™ of ₹180.74. GuruFocus considers Sangal Papers to be Fairly Valued.

Key valuation signals for BOM:516096:

  • Other Stockholders Equity: ₹454 Mil
  • GF Value™: ₹180.74 vs. price of ₹175.00 (3.2% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the BOM:516096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sangal Papers Business Description

Address 22km stone, Meerut-Mawana road, Village Bhainsa, Mawana, Meerut, UP, IND, 250401
Sangal Papers Ltd is an India-based company. Its main business activity involves the manufacturing and trading of paper and paper products. The company's product line includes envelope papers, ribbed papers, packing and lamination papers, scrapbook and crafts paper, color paper, writing and printing paper, stationery papers, newsprint papers, and others. The company sells its products in India and also exports to international countries, with the majority of its revenue coming from sales within India.
58GF Score

Get the complete analysis for BOM:516096

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹175.00
Price
₹180.74
GF Value